20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11339 | Furegrelate sodium | U-63557A | PPAR |
Furegrelate sodium (U-63557A) is a selective thromboxane synthase inhibitor with oral activity. Furegrelate sodium(U-63557A) inhibits thromboxane A2 (TXA2) synthase in human platelet microsomes with an IC50 of 15 nM. | |||
T9865 | Almonertinib mesylate | EGFR | |
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer st... | |||
TN5073 | Strophanthidin | Strophanthidine | ATPase , Calcium Channel |
Strophanthidin (Strophanthidine) can induce calcium overload in vivo. | |||
T1457 | Deferasirox | ICL 670,CGP-72670 | Others , Ferroptosis , Antibacterial |
Deferasirox (CGP-72670) is an oral iron chelating agent used to treat chronic iron overload. | |||
T2923 | Apremilast | CC-10004 | Apoptosis , TNF , PDE |
Apremilast (CC-10004) (CC-10004) is a potent and orally active PDE4 (IC50=74 nM) with anti-inflammation activities. | |||
T16841 | SAR-260301 | PI3K | |
SAR-260301 is an orally available and selective inhibitor of PI3Kβ (IC50: 23 nM). | |||
T31668 | Eribaxaban | PD 348292,PD0348292,PD-0348292,PD-348292,PD 0348292,PD348292 | Factor Xa |
Eribaxaban (PD348292) is an orally available factor Xa inhibitor for the prevention and treatment of venous thromboembolism. | |||
T15715 | LAS101057 | Adenosine Receptor | |
LAS101057 is a novel orally available and potent and selective A2B receptor antagonist for the study of asthma. | |||
T5368 | Eicosapentaenoic Acid | Histone Demethylase , Others , Endogenous Metabolite | |
Eicosapentaenoic Acid (EPA) is a ω-3 fatty acid abundantly available in marine organisms. | |||
T15423 | GSK-7975A | Calcium Channel | |
GSK-7975A is a potent and orally available inhibitor of CRAC channel. | |||
T27812 | Leminoprazole | ATPase | |
Leminoprazole is an orally available H+,K(+)-ATPase inhibitor that protects gastric mucosal cells from various cellular damages. | |||
T6585 | SAR405838 | MI773,MI 773,MI-77301,MI-773 | Mdm2 , E1/E2/E3 Enzyme |
MI-773 (SAR405838 (MI 773)) is an orally available MDM2 antagonist with Ki of 0.88 nM. Phase 1. | |||
T13111 | Tegadifur | 40497S,FD 1 | Others |
Tegadifur (40497S) is an orally available antitumor compound with antimetabolic effects, often used with uracil and in the treatment of rectal adenocarcinoma. | |||
TQ0266 | MSC2530818 | CDK | |
MSC2530818 is an effective, selective and orally available CDK8 inhibitor (IC50: 2.6 nM). | |||
T71394 | BMS-823778 | ||
BMS-823778 is an orally available potent and selective inhibitor of 11-β-hydroxysteroid-dehydrogenase 1 (11βHSD-1). BMS-823778 is a potential therapeutic agent for type 2 diabetes mellitus (T2DM). | |||
T26631L | Anidoxime HCl | USVP-E142,Anidoxime HCl( 34297-34-2 Free base) | |
Anidoxime HCl (USVP-E142) is a novel orally available compound with anti-analgesic activity. | |||
T33836L | Oxamisole TFA | Oxamisole TFA(99258-56-7 Free base) | Antiviral |
Oxamisole TFA is an orally available T-cell immune repair agent. | |||
T23297 | (S)-(+)-Dimethindene maleate | AChR , Histamine Receptor | |
(S)-(+)-Dimethindene maleate is an orally available, selective muscarinic M2 receptor and histamine H1 receptor antagonist that inhibits muscarinic M1, M3, and M4 receptors. | |||
T39707 | AS-1763 | BTK | |
AS-1763 is an orally available and selective BTK inhibitor with an IC50 of 0.85 nM. | |||
T15575 | Indeglitazar | PPM 204 | PPAR |
Indeglitazar (PPM 204) is orally available pan-agonist of PPAR (PPAR subtypes alpha (α), delta (δ), and gamma (γ)). |